Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2021. Start Trial.
Date Value
October 02, 2026 1.380
October 01, 2026 1.367
September 30, 2026 1.389
September 29, 2026 1.401
September 28, 2026 1.411
September 25, 2026 1.448
September 24, 2026 1.472
September 23, 2026 1.486
September 22, 2026 1.564
September 21, 2026 1.506
September 18, 2026 1.520
September 17, 2026 1.513
September 16, 2026 1.509
September 15, 2026 1.506
September 14, 2026 1.469
September 11, 2026 1.448
September 10, 2026 1.550
September 09, 2026 1.564
September 08, 2026 1.621
September 04, 2026 1.635
September 03, 2026 1.710
September 02, 2026 1.703
September 01, 2026 1.645
August 31, 2026 1.693
August 28, 2026 1.693
Date Value
August 27, 2026 1.767
August 26, 2026 1.747
August 25, 2026 1.774
August 24, 2026 1.757
August 21, 2026 1.798
August 20, 2026 1.781
August 19, 2026 1.808
August 18, 2026 1.706
August 17, 2026 1.771
August 14, 2026 1.716
August 13, 2026 1.764
August 12, 2026 1.720
August 11, 2026 1.628
August 10, 2026 1.537
August 07, 2026 1.530
August 06, 2026 1.513
August 05, 2026 1.489
August 04, 2026 1.492
August 03, 2026 1.414
July 31, 2026 1.401
July 30, 2026 1.435
July 29, 2026 1.376
July 28, 2026 1.438
July 27, 2026 1.479
July 24, 2026 1.465

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 2.628
Alnylam Pharmaceuticals, Inc. 21.70
Savara, Inc. 6.877
Vericel Corp. 5.552
Biogen, Inc. 1.723

Price to Book Value Related Metrics

Price 4.07
Earnings Yield -25.35%
Market Cap 263.32M